Get more replies from employers
Send a job-specific resume in minutes.
Tempus is seeking an Associate Director RWE, PharmaR&D in Boston, MA (with NYC and Chicago locations) to design and execute real-world evidence studies for oncology drug development. The role requires deep RWD expertise, strong communication, and collaboration across cross-functional teams.
You will guide methodological approaches, lead analysis projects, and work with biopharma partners to translate data into actionable insights for precision medicine.
Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Associate Director RWE, PharmaR&D Locations: Boston, MA | New York City, NY | Chicago, IL Are you passionate about using clinico-genomics to transform cancer therapeutic care? Tempus is a technology company at the forefront of the expansion of multi-modal healthcare data generation and the application of artificial intelligence (AI) to fundamentally change cancer care. Tempus is growing, and we are seeking exciting new talent to join the team.
Tempus' proprietary platform connects an entire ecosystem of real-world data to deliver real-time, actionable insights to physicians and drug developers. As a Tempus employee you will have access to the world’s largest real-world patient clinical data set linked to claims, genetics, and digital pathology. Our data empowers researchers to better characterize and understand disease, and to drive better outcomes through precise, individualized care. The Associate Director RWE, PharmaR&D, will design, propose and execute research projects for Tempus’s top biopharmaceutical partners. This role will require staying up to date in research and industry trends in oncology drug development to identify specific areas where the Tempus platform can provide impact to our partners portfolio. This role involves performing complex computational analyses and guiding algorithm development for advancing cancer precision medicine for patients across the Tempus network. The ideal candidate will possess strong real-world data analytical skills, experience in applying machine learning and statistical models to big data, and the ability to communicate complex findings to various stakeholders.
CHI: $155,000-$200,000 USD NYC/SF: $165,000-$210,000 USD The expected salary range may vary for other locations. Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.